Skip to content

Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC Study

Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07773818
Enrollment
32
Registered
2026-08-19
Start date
2026-08-06
Completion date
2029-09-01
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meta-Learning, Multimodal, Predictive Models, Triple -Negative Breast Cancertriple

Brief summary

Based on the UPGRADE-TNBC study, a high-quality TNBC sample repository was established. By integrating multi-source data-including clinical information, radiomics, pathological images, and molecular sequencing-and innovatively incorporating a meta-learning strategy, a treatment response prediction model based on multimodal small-sample learning was developed. This approach aims to optimize drug combinations and precisely identify patient subgroups likely to benefit from treatment, thereby providing a new paradigm for personalized therapy in early-stage TNBC.

Interventions

Collect multi-source data from patients, including clinical information, radiomics, pathological images, and molecular sequencing

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* The UPGRADE-TNBC Study Population

Exclusion criteria

* Populations outside the UPGRADE-TNBC study

Design outcomes

Primary

MeasureTime frameDescription
Model building2 yearsA predictive model for neoadjuvant therapy in TNBC was successfully established

Countries

China

Contacts

CONTACTXue Wang
wxyxyuki@163.com86-010-87787242

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026